Crescita Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Crescita Therapeutics has a total shareholder equity of CA$18.8M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$24.6M and CA$5.8M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$9.39m |
| Equity | CA$18.82m |
| Total liabilities | CA$5.78m |
| Total assets | CA$24.60m |
Recent financial health updates
Recent updates
Why Investors Shouldn't Be Surprised By Crescita Therapeutics Inc.'s (TSE:CTX) 33% Share Price Surge
Jan 04
Is Crescita Therapeutics (TSE:CTX) Using Debt Sensibly?
Nov 18Increases to CEO Compensation Might Be Put On Hold For Now at Crescita Therapeutics Inc. (TSE:CTX)
May 05Crescita Therapeutics Inc.'s (TSE:CTX) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 10
Financial Position Analysis
Short Term Liabilities: CTX's short term assets (CA$18.5M) exceed its short term liabilities (CA$4.9M).
Long Term Liabilities: CTX's short term assets (CA$18.5M) exceed its long term liabilities (CA$912.0K).
Debt to Equity History and Analysis
Debt Level: CTX is debt free.
Reducing Debt: CTX has no debt compared to 5 years ago when its debt to equity ratio was 23.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CTX has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CTX is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 18.5% per year.